insights_auto
Why is EDIT down 4.09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.64
arrow_downward
-4.09%(-0.070) 1D
$1.66
arrow_upward
+1.22% (+0.020)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
TradingView
·
1 hour ago
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
Yahoo Finance
·
3 hours ago
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Nacionale
·
6 hours ago
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Beinsure
·
8 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com